BAC vs VRDN Stock Comparison

Compare BAC vs VRDN on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.

Market data as of Nov 15, 2026 market close· AIQ score gap 0 points
BAC
Financial Services
vs
VRDN
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
VRDN
Viridian Therapeutics, Inc.
Price
$30.87
Day move
+1.28%
AIQ Score
58/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and VRDN?

BAC and VRDN are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Viridian Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 1/10

BAC and VRDN are effectively level

BAC and VRDN are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.

Evidence agreement: 0 of 6Comparison trend: Weakening
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
VRDN

Viridian Therapeutics, Inc.

AIQ Score
58/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score does not currently separate BAC and VRDN as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.

Compare Bank of America Corporation and Viridian Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
VRDN
+62.5%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · VRDN $16,247

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and VRDN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
VRDN advantage
  • Momentum37 vs 91
    VRDN +54
  • Risk Resilience83 vs 46
    BAC +37
  • Value68 vs 37
    BAC +31
  • Quality64 vs 41
    BAC +23

Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
VRDN0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 9 active signals are unchanged.

Deeper signal detail for each name lives on its own signals page — BAC and VRDN both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

Even

Neither separates on the overall score.

Growth

VRDN

VRDN on combined revenue and EPS growth.

Value

BAC

BAC on the peer-relative Value factor, by 31 points.

Momentum

VRDN

VRDN on the Momentum factor, by 54 points.

Lower downside

BAC

BAC on Risk Resilience, by 37 points.

Analyst upside

VRDN

VRDN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACVRDNNote
Implied upside to target+24.1%+31.2%VRDN has more room
Target dispersion+25.3%+12.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2517Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

How each independent group of evidence reads the pair.

Evidence groupFavorsReading
AIQ ScoreEven58 vs 58
FundamentalsVRDNon balancerevenue growth -3.3% vs 89.7%; EPS growth -23.8% vs 22.9%; TTM ROE 2.3% vs -17.4%; gross margin 60.4% vs 93%; operating margin 22.4% vs -17.8% — VRDN takes 3 of 5 decided legs, not all of them
ValuationBACValue 68 vs 37
TechnicalsVRDNPrice vs 50-day -5.6% vs 35.7%; vs 200-day -7% vs 43.2%
Risk ResilienceBACRisk Resilience 83 vs 46
Analyst expectationsVRDNTarget upside 24.1% vs 31.2%

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 0 points. (argues the conclusion is provisional)
  • Only 0 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BAC lead: Weakening — the AIQ differential moved from 6 to 0 points over 30 sessions.

May 27BAC leads above the line · VRDN leads belowNov 13
Today
Level
58 vs 58
7 sessions ago
BAC +2
58 vs 56
30 sessions ago
BAC +6
62 vs 56
90 sessions ago
BAC +24
71 vs 47

The lead changed hands once in this window, most recently on Nov 5 when BAC moved ahead of VRDN.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
VRDNConflicted

5 bullish / 2 bearish / 2 neutral, conflicted

Only VRDN

  • Golden Cross Active — bullish, trend, long horizon (5.52%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.37%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.42x)
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

VRDNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.28%, AIQ 0 points).

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

VRDN leads on balance
MetricBACVRDN
Revenue growth (YoY)-3.3%89.7%
EPS growth (YoY)-23.8%22.9%
Gross margin60.4%93%
Operating margin22.4%-17.8%
Return on equity (TTM)2.3%-17.4%
Debt to equity1.280.42

Performance

VRDN leads 6 of 6 windows
MetricBACVRDN
1 week (5 sessions)3.2%8.4%
1 month (20 sessions)-0.4%62.2%
3 months (63 sessions)-20.1%33.7%
6 months (126 sessions)2.5%83.5%
Year to date-7.2%-0.8%
1 year (252 sessions)-5.7%6.7%

Technicals

VRDN has the stronger structure
MetricBACVRDN
RSI (14)45.977.3
ADX (14)27.251
Price vs 50-day-5.6%35.7%
Price vs 200-day-7%43.2%
Volatility (1M, annualized)24.8%69.7%

Risk

BAC is the more resilient
MetricBACVRDN
Beta0.791.14
Sharpe ratio-0.220.43
Sortino ratio-0.290.62
Max drawdown-23.7%-60.6%
Current drawdown-21.3%-8.6%
Annualized volatility22.4%72%
Value at risk (95%)-2.6%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which has more analyst upside, BAC or VRDN?

Analyst price targets imply +24.1% upside for BAC and +31.2% for VRDN, so the Street currently favors VRDN. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or VRDN?

BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 31 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or VRDN?

VRDN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or VRDN?

VRDN on the Momentum factor, by 54 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or VRDN?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 37 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than VRDN?

The profitability evidence is mixed: gross margin 60.4% vs 93%; operating margin 22.4% vs -17.8%; ttm roe 2.3% vs -17.4%. BAC leads on two measures and VRDN on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

What do the current signals say about BAC and VRDN?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. VRDN: 5 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On VRDN it is Golden Cross Active (bullish, long horizon).

Compare BAC and VRDN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.